Home Cart Sign in  
Chemical Structure| 130-95-0 Chemical Structure| 130-95-0

Structure of Quinine
CAS No.: 130-95-0

Chemical Structure| 130-95-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Quinine is a medication used to treat malaria and babesiosis, isolated from the bark of a cinchona tree.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Quinine

CAS No. :130-95-0
Formula : C20H24N2O2
M.W : 324.42
SMILES Code : O[C@H](C1=CC=NC2=CC=C(OC)C=C12)[C@H]3[N@@]4C[C@H](C=C)[C@](CC4)([H])C3
MDL No. :MFCD00198096
InChI Key :LOUPRKONTZGTKE-WZBLMQSHSA-N
Pubchem ID :3034034

Safety of Quinine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H317
Precautionary Statements:P261-P264-P270-P280-P301+P312-P302+P352

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human sinonasal epithelial cells 1% 10 minutes Quinine significantly increased ciliary beat frequency (CBF). Front Immunol. 2018 Mar 28;9:624.
Human sinonasal epithelial cells 0.01% and 0.1% 15 minutes Quinine stimulation led to increased NO production, confirmed by DAF-FM fluorescence. Front Immunol. 2018 Mar 28;9:624.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice Mice skin abrasion infection model Topical administration 0.2 mg/cm² Single administration, continued until total radiant exposure reached 135 J/cm² To evaluate the antimicrobial effects of quinine hydrochloride (Q-HCL) combined with antimicrobial blue light (aBL) in a Mice skin abrasion infection model. Results showed that the combination treatment significantly reduced bacterial bioluminescence signals, achieving a 3.08-log10 RLU reduction, with no recurrence observed 24 hours post-treatment. J Infect Dis. 2020 Feb 3;221(4):618-626

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.08mL

0.62mL

0.31mL

15.41mL

3.08mL

1.54mL

30.82mL

6.16mL

3.08mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories